This federal contract opportunity closed on June 29, 2026. The deadline for submissions has passed.
Similar active opportunities:
This opportunity has closed
Response deadline was June 29, 2026
Similar active opportunities you might be interested in:
View all similar opportunitiesThe Department of War (DoW) is required by law (10 U.S.C. 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting,
The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing in AURORA, CO.
Looking for more opportunities?
Browse our full directory of government contracts